首页> 美国卫生研究院文献>other >Detecting TP53 mutations in diagnostic and archival liquid-based Pap samples from ovarian cancer patients using an ultra-sensitive ddPCR method
【2h】

Detecting TP53 mutations in diagnostic and archival liquid-based Pap samples from ovarian cancer patients using an ultra-sensitive ddPCR method

机译:使用超灵敏ddPCR方法检测卵巢癌患者的诊断性和档案性液基Pap样品中的TP53突变

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

High-grade serous ovarian cancer (HGSOC) is the most common subtype of epithelial ovarian cancer and early detection is challenging. TP53 mutations are a hallmark of HGSOC and detection of these mutations in liquid-based Pap samples could provide a method for early diagnosis. Here we evaluate the use of IBSAFE, an ultra-sensitive droplet digital PCR (ddPCR) method, for detecting TP53 mutations in liquid-based Pap samples collected from fifteen women at the time of diagnosis (diagnostic samples) and/or up to seven years prior to diagnosis (archival samples). We analysed tumours for somatic TP53 mutations with next generation sequencing and were able to detect the corresponding mutations in diagnostic samples from six of eight women, while one patient harboured a germline mutation. We further detected a mutation in an archival sample obtained 20 months prior to the ovarian cancer diagnosis. The custom designed IBSAFE assays detected minor allele frequencies (MAFs) with very high assay sensitivity (MAF = 0.0068%) and were successful despite low DNA abundance (0.17–206.14 ng, median: 17.27 ng). These results provide support for further evaluation of archival liquid-based Pap samples for diagnostic purposes and demonstrate that ultra-sensitive ddPCR should be evaluated for ovarian cancer screening in high-risk groups or in the recurrent setting.
机译:高度浆液性卵巢癌(HGSOC)是上皮性卵巢癌的最常见亚型,早期发现具有挑战性。 TP53突变是HGSOC的标志,在基于液体的Pap样品中检测这些突变可为早期诊断提供一种方法。在这里,我们评估了使用IBSAFE(一种超灵敏的液滴数字PCR(ddPCR)方法)在检测时(诊断样品)和/或长达7年的时间从​​15位妇女收集的液体基巴氏液样本中检测TP53突变的用途。诊断之前(档案样本)。我们用下一代测序方法分析了肿瘤中的TP53体细胞突变,并能够从八名女性中的六名女性的诊断样本中检测到相应的突变,而一名患者则带有种系突变。我们进一步在卵巢癌诊断前20个月获得的档案样本中检测到突变。定制设计的IBSAFE分析以极高的分析灵敏度(MAF = 0.0068%)检测到次要等位基因频率(MAF),尽管DNA丰度低(0.17-206.14 ng,中位数:17.27 ng),但还是成功的。这些结果为进一步评估基于档案的基于液体的Pap样品以用于诊断目的提供了支持,并表明应该对高危人群或复发环境中的超敏ddPCR进行卵巢癌筛查。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号